Forensic Context

A study in humans identified the miR-26a-5p as a predicted post-transcriptional regulator of key hub proteins in cardiomyopathy, specifically noting it as a risk factor that slows the development of several cardiac conditions [Rahman et al. DOI:10.1038/s41598-024-78011-3]. In separate human skin research, the miR-26a-5p was found to be downregulated in burn hypertrophic scar tissue compared to normal skin [Siu et al. DOI:10.1111/wrr.13100]. A study in Wistar rats demonstrated that the miR-26a-5p was significantly downregulated (fold change 0.496159) in skeletal muscle three days after a 30% TBSA burn injury, identifying it as a potential biomarker for skeletal muscle wasting [Zhang et al. DOI:10.5505/tjtes.2015.80707]. In humans, research on marathon runners showed the miR-26a-5p was significantly upregulated in serum after strenuous exercise in individuals with high cardiac troponin T levels (fold change median 1.11 vs 0.6, p=0.046) and exhibited a positive correlation with cTnT (r=0.2, p=0.02), suggesting its release kinetics during myocardial stress may differ from cardiac troponin, potentially adding diagnostic accuracy in a multi-marker strategy for myocardial infarction [Shirvani Samani et al. DOI:10.3390/jcm11010005].